Revance Stock Investor Sentiment

RVNC Stock  USD 3.78  0.24  5.97%   
About 68% of Revance's investor base is looking to short. The analysis of overall sentiment of trading Revance stock suggests that many investors are alarmed at this time. The current market sentiment, together with Revance's historical and current headlines, can help investors time the market. In addition, many technical investors use Revance stock news signals to limit their universe of possible portfolio assets.
  

Revance Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Revance can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a month ago at www.macroaxis.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
news
over a month ago at thelincolnianonline.com         
Revance Therapeutics Coverage Initiated by Analysts at StockNews.com
news
over a month ago at bizjournals.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
bizjournals News
over a month ago at bizjournals.com         
Revance Therapeutics merger delayed due to alleged contract breech
bizjournals News
over a month ago at seekingalpha.com         
Revance Therapeutics, Crown Labs tender offer extended until Oct. 18
seekingalpha News
over a month ago at finance.yahoo.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Yahoo News
over a month ago at finance.yahoo.com         
Cosmetic Surgery Market Size Projected to Reach USD 94.5 Billion by 2032 with a CAGR of 5.8 percent ...
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Yahoo News
over a month ago at finance.yahoo.com         
Botulinum Toxin Market Size Projected to Reach USD 21.6 Billion by 2032 with a 9.4 percent CAGR - SN...
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
Macroaxis News
over two months ago at thelincolnianonline.com         
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
news
over two months ago at thelincolnianonline.com         
Analysts Set Revance Therapeutics, Inc. PT at 10.50
news
Far too much social signal, news, headlines, and media speculation about Revance that are available to investors today. That information is available publicly through Revance media outlets and privately through word of mouth or via Revance internal channels. However, regardless of the origin, that massive amount of Revance data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Revance news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revance relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revance's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revance alpha.

Revance Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3
09/05/2024
2
Glancy Prongay Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Revance Therapeutics, Inc. on Behalf of Investors
10/16/2024
3
Revance Therapeutics, Inc. Being Investigated on Behalf of Revance Therapeutics, Inc. Investors. Contact Levi Korsinsky For Details
10/28/2024
4
Arcellx, Inc. Reports Q3 Loss, Lags Revenue Estimates
11/07/2024
5
Disposition of 08 shares by Hollander David of Revance at 4.17 subject to Rule 16b-3
11/18/2024

Complementary Tools for Revance Stock analysis

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency